{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:24:41Z","timestamp":1790342681173,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010358","name":"KV Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010727","name":"Axel Muusfeldts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016953","name":"Comprehensive Cancer Center, University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009584","name":"Toyota Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.lungcan.2025.108528","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:37:25Z","timestamp":1743946645000},"page":"108528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5154-858X","authenticated-orcid":false,"given":"L\u00e6rke","family":"Rosenlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-0150","authenticated-orcid":false,"given":"Kasper","family":"Guldbrandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Barlebo","family":"Ahlborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0981-7518","authenticated-orcid":false,"given":"Martin","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Skougaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Albrecht-Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Marie","family":"Nellemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krakauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9321-0781","authenticated-orcid":false,"given":"Peter Michael","family":"G\u00f8rtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Fledelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lerberg","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0122-0916","authenticated-orcid":false,"given":"Paw Christian","family":"Holdgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Steen","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Marie","family":"Gr\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"H\u00f8jsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-1869","authenticated-orcid":false,"given":"Rene Horsleben","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Borgbjerg","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-312X","authenticated-orcid":false,"given":"Morten","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-0210","authenticated-orcid":false,"given":"Malene St\u00f8chkel","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette Haar","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2693-8617","authenticated-orcid":false,"given":"Zaigham","family":"Saghir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-8662","authenticated-orcid":false,"given":"Mette","family":"P\u00f8hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Borissova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-7987","authenticated-orcid":false,"given":"Lotte Holm","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Saks\u00f8","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene S\u00f8by","family":"Christophersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Hilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor Lind","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe H\u00f8yer","family":"Simonsen Schwaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-9209","authenticated-orcid":false,"given":"Uffe","family":"Bodtger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Nowak","family":"Lonsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-4134","authenticated-orcid":false,"given":"Christian Niels","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6335-3303","authenticated-orcid":false,"given":"Oke","family":"Gerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben Riis","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hjorthaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Richter","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meldgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Malene","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-8099","authenticated-orcid":false,"given":"Boe Sandahl","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108528_b0005","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. [updated: 2024 Jun 27; cited 2024 Aug 26]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2023 Submission (1975-2021), SEER 22 registries. 2024; Available from: Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"10.1016\/j.lungcan.2025.108528_b0010","unstructured":"J. Ferlay, F. Lam, M. Laversanne, M. Colombet, L. Mery, M. Pi\u00f1eros, A. Znaor, I. Soerjomataram, F. Bray, Global Cancer Observatory: Cancer Today (version 1.1). 2024 (08.02.2024) 19-03-2024]; Available from: Available from: https:\/\/gco.iarc.who.int\/today."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108528_b0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.21.02528","article-title":"Management of stage III non-small-cell lung cancer: ASCO guideline","volume":"40","author":"Daly","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"suppl_4","key":"10.1016\/j.lungcan.2025.108528_b0020","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann. Oncol."},{"issue":"302","key":"10.1016\/j.lungcan.2025.108528_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab0021","article-title":"Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer","volume":"7","author":"Garcia-Murillas","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108528_b0030","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.15252\/emmm.201404913","article-title":"Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease","volume":"7","author":"Olsson","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"14","key":"10.1016\/j.lungcan.2025.108528_b0035","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","article-title":"Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence","volume":"25","author":"Coombes","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108528_b0040","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1038\/ncomms8686","article-title":"Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients","volume":"6","author":"Sausen","year":"2015","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108528_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145754","article-title":"Personalized circulating Tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108528_b0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","article-title":"Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis","volume":"73","author":"Birkenkamp-Demtr\u00f6der","year":"2018","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108528_b0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/annonc\/mdz048","article-title":"Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA","volume":"30","author":"Tan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108528_b0060","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.10.039","article-title":"Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer","volume":"158","author":"Azad","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lungcan.2025.108528_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2024.100802","article-title":"ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach","volume":"39","author":"Nielsen","year":"2024","journal-title":"Cancer Treatment and Research Communications"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108528_b0070","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2025.108528_b0075","doi-asserted-by":"crossref","DOI":"10.1007\/s11684-024-1060-z","article-title":"Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification","author":"Fu","year":"2024","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108528_b0080","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2159-8290.CD-21-1486","article-title":"Longitudinal undetectable molecular residual disease defines potentially cured population in localized non-small cell lung cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108528_b0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1878-0261.13116","article-title":"Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer","volume":"16","author":"Waldeck","year":"2022","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108528_b0090","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41467-021-27022-z","article-title":"Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC","volume":"12","author":"Qiu","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108528_b0095","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108528_b0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol. Diagn. Ther."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108528_b0105","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108528_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/cyt.13246","article-title":"The use of minimal residual disease in thoracic oncology: gaps between promises and the on-the-ground reality of daily practice","volume":"35","author":"Hofman","year":"2024","journal-title":"Cytopathology"},{"issue":"7655","key":"10.1016\/j.lungcan.2025.108528_b0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108528_b0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.annonc.2022.02.007","article-title":"Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer","volume":"33","author":"Gale","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2025.108528_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.15281","article-title":"Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments","author":"Oh","year":"2024","journal-title":"Thorac Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108528_b0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cncr.33985","article-title":"Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer","volume":"128","author":"Li","year":"2022","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.lungcan.2025.108528_b0135","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1158\/1078-0432.CCR-21-3044","article-title":"Perioperative ctDNA-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (LUNGCA-1)","volume":"28","author":"Xia","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108528_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.06.024","article-title":"Analysis of circulating tumor DNA predicts outcomes of short-course consolidation immunotherapy in unresectable stage III NSCLC","author":"Jun","year":"2024","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108528_b0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s43018-019-0011-0","article-title":"Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small cell lung cancer","volume":"1","author":"Moding","year":"2020","journal-title":"Nat Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108528_b0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/1878-0261.13387","article-title":"Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study","volume":"17","author":"Fu","year":"2023","journal-title":"Mol. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108528_b0155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1759-7714.15251","article-title":"Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non-small cell lung cancer","volume":"15","author":"Tian","year":"2024","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108528_b0160","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.cllc.2019.11.002","article-title":"Surveillance with PET\/CT and liquid biopsies of stage I-III lung cancer patients after completion of definitive therapy: a randomized controlled trial (SUPER)","volume":"21","author":"Skougaard","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108528_b0165","unstructured":"R Core Team,_R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing (2023), Vienna, Austria. <https:\/\/www.R-project.org\/>."},{"key":"10.1016\/j.lungcan.2025.108528_b0170","unstructured":"T. Therneau,_A Package for Survival Analysis in R_. R package version 3.7-0, <https:\/\/CRAN.R-project.org\/package=survival>. Terry M. Therneau, Patricia M. Grambsch (2000)._Modeling Survival Data: Extending the Cox Model_. Springer, New York. ISBN 0-387-98784-3, (2024)."},{"key":"10.1016\/j.lungcan.2025.108528_b0175","unstructured":"A. Kassambara, M. Kosinski, P. Biecek, survminer: Drawing Survival Curves using 'ggplot2'_. R package version 0.4.9, <https:\/\/CRAN.R-project.org\/package=survminer>., (2021)."},{"key":"10.1016\/j.lungcan.2025.108528_b0180","article-title":"_forestplot: advanced forest plot using 'grid'","volume":"3.1.3","author":"Gordon","year":"2023","journal-title":"Graphics_. R Package Version"},{"key":"10.1016\/j.lungcan.2025.108528_b0185","unstructured":"J. Weiss, W. Xu,_swimplot: Tools for Creating Swimmers Plots using 'ggplot2'_. R package version 1.2.0, <https:\/\/CRAN.R-project.org\/package=swimplot>, (2021)."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108528_b0190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lungcan.2025.108528_b0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/PO.20.00046","article-title":"Clonal hematopoiesis in late-stage non-small-cell lung cancer and its impact on targeted panel next-generation sequencing","volume":"4","author":"Yaung","year":"2020","journal-title":"JCO Precis. Oncol."},{"issue":"19","key":"10.1016\/j.lungcan.2025.108528_b0200","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","article-title":"Intratumor heterogeneity: evolution through space and time","volume":"72","author":"Swanton","year":"2012","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.lungcan.2025.108528_b0205","doi-asserted-by":"crossref","first-page":"21559","DOI":"10.18632\/aging.103945","article-title":"Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108528_b0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41416-022-01776-9","article-title":"Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges","volume":"127","author":"Garc\u00eda-Pardo","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108528_b0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108528_b0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40487-021-00144-6","article-title":"When tissue is an issue the liquid biopsy is nonissue: a review","volume":"9","author":"Rodr\u00edguez","year":"2021","journal-title":"Oncol. Ther."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108528_b0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0284185113498536","article-title":"Diagnostic efficacy of PET and PET\/CT for recurrent lung cancer: a meta-analysis","volume":"55","author":"He","year":"2014","journal-title":"Acta Radiol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108528_b0230","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.athoracsur.2018.08.015","article-title":"Comparing two imaging methods for follow-up of lung cancer treatment: a randomized pilot study","volume":"107","author":"Gambazzi","year":"2019","journal-title":"Ann. Thorac. Surg."},{"issue":"346","key":"10.1016\/j.lungcan.2025.108528_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108528_b0240","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/gutjnl-2014-308859","article-title":"Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery","volume":"65","author":"Reinert","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108528_b0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13045-022-01355-8","article-title":"Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108528_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40644-022-00491-1","article-title":"CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT)","volume":"22","author":"Al-Umairi","year":"2022","journal-title":"Cancer Imaging"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:28:28Z","timestamp":1777782508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225004209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"alternative-id":["S0169500225004209"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108528","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108528"}}